An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
about
Ethyl Pyruvate: An Anti-Microbial Agent that Selectively Targets Pathobionts and BiofilmsPreparation of supramolecular hydrogel-enzyme hybrids exhibiting biomolecule-responsive gel degradation.Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.Overcoming T. gondii infection and intracellular protein nanocapsules as biomaterials for ultrasonically controlled drug release.Emerging hydrogel designs for controlled protein delivery.Encapsulation of Adenovirus BMP2-Transduced Cells with PEGDA Hydrogels Allows Bone Formation in the Presence of Immune Response.Local pulsatile PTH delivery regenerates bone defects via enhanced bone remodeling in a cell-free scaffold.Intestinal barrier integrity and inflammatory bowel disease: Stem cell-based approaches to regenerate the barrier.Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancerSynergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft.Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems.Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.Biomimetic nanoparticles with enhanced affinity towards activated endothelium as versatile tools for theranostic drug delivery.Nanofibrous peptide hydrogel elicits angiogenesis and neurogenesis without drugs, proteins, or cells.Nano-carrier mediated co-delivery of methyl prednisolone and minocycline for improved post-traumatic spinal cord injury conditions in rats.Towards an arthritis flare-responsive drug delivery system.Inflammatory diseases: Hydrogel drug delivery for inflammatory bowel disease.Antimicrobial hydrogels: promising materials for medical application.
P2860
Q28554303-78F9752B-5732-496C-84FC-AE8A176A8968Q36112722-2EADA342-68F6-462F-BBBC-AD054949636DQ37469872-ED8613A0-7021-4276-9FB4-732CC6C74F1DQ38641476-8B4FB08C-1D19-4F72-A2FB-34B6FAE950AAQ38884998-FDE50126-5A35-47F6-937D-136F10C0E61CQ39101941-5A45821A-62E3-48FE-9780-40D0AFFEA9D1Q39195487-29898C8A-D281-460C-A50F-C2EB410536CEQ39388017-8895EB13-4182-432B-9AF7-D381B4C0E56DQ42176588-EDBCF190-1C93-4B83-BE09-6AF0F512271AQ42366470-FC38CE5D-A2DF-4AA1-8B9D-96E0EE99E244Q47690085-53E17577-A263-4F2F-A39D-163701A0D1A5Q47754415-CBB383FC-12AE-40EC-A573-E27A077EC4DAQ47980720-0D51CD0A-7B45-4AF8-903B-1571CE7D8478Q49788067-93812E6C-CFF4-4A59-BA2D-A4A7101ED750Q50110984-0C4B4797-42F8-49E4-B9E5-C52531AE9AE3Q51103965-A99B484C-C0FC-4D6A-B91B-11ED7A2B1D5BQ52721914-65FD552F-EC39-4DD5-8B01-36079F215337Q53338831-6DB8374D-6BA8-4635-921C-E07B55F76DC4Q53691449-168220CE-3332-43B3-9A99-CE7DE7CE8AF0
P2860
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
@ast
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
@en
type
label
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
@ast
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
@en
prefLabel
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
@ast
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
@en
P2093
P2860
P921
P1476
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
@en
P2093
Allen Zhou
Bonnie Cao
Giovanni Traverso
Jeffrey M Karp
Joerg Ermann
Jonathan N Glickman
Joshua R Korzenik
Marc D Succi
Matthew J Hamilton
Praveen K Vemula
P2860
P304
P356
10.1126/SCITRANSLMED.AAA5657
P407
P577
2015-08-01T00:00:00Z